JPRN-UMIN000017624已完成未知
Platelet response to prasugrel and clopidogrel loadinig doses in elective PCI patients - Comparison of platelet responses to different thienopyridines
Division of Cardiovascular Medicine, Jichi Medical University School of Medicine0 个研究点目标入组 40 人开始时间: 2015年5月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Concomitant use of other antiplatelet drugs other than aspirin. (2)Participation in other clinical trial. (3)Platelet counts of <10x107/ml or >40x107/ml (4)Malignant disease or autoimmune disease. (5)Judgment by physician that a patient is inappropriate to enroll the study. (6)Patient who have communication difficulty.
研究者
相似试验
招募中
3 期
PRACTICAL TRIAACTRN12605000581662Cardiology Dept, Royal Perth Hospital370
尚未招募
不适用
The antiplatelet function of prasugrel and clopidogrelJPRN-jRCT1031220254Isoda Kikuo100
Unknown
不适用
Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Patients With Acute Coronary SyndromeNCT01090336Heidelberg University26
已完成
3 期
The effect of the antiplatelet drug Prasugrel on the interactions between immune cells and the blood clotting cells platelets in patients with cardiovascular disease.AtherosclerosisACTRN12612001157864Capital and Coast District Heath Board24
已完成
4 期
Platelet Inhibition in Patients With Systolic Heart FailureSystolic Heart FailureNCT01765400University of Nebraska30